Completed
Regional focus
Global
Topics
Since the First International Summit on Human Genome Editing was held in 2015 in Washington, D.C., research on human genome editing has continued to advance rapidly. However, many questions remain about the science, application, ethics, and governance of human genome editing. Of particular concern is the possibility of heritable genome editing, which would alter the human germline, and applications for purposes other than to treat disease or disability. The Second International Summit on Human Genome Editing was convened to advance the global dialogue on these issues.
- Statement by the Organizing Committee of the Second International Summit on Human Genome Editing Nov 28, 2018 Statement
- U.S. NAS and NAM Presidents Issue Statement on the Second International Summit on Human Genome Editing Nov 28, 2018 Statement
- Human Genome Editing Summit Kicks Off in Hong Kong Nov 27, 2018 News Release
- Organizing Committee Named for the Second International Summit on Human Genome Editing May 29, 2018 News Release
Featured publication
Workshop_in_brief
·2019
On November 27-29, 2018, the U.S. National Academy of Sciences and U.S. National Academy of Medicine, the Royal Society of the United Kingdom, and the Academy of Sciences of Hong Kong convened the Second International Summit on Human Genome Editing at the University of Hong Kong. The summit brought...
View details
Description
Building upon the outcome of the 2015 International Summit on Human Gene Editing, which called for ongoing international discussions on human gene editing, an ad hoc committee under the auspices of the NAS and NAM will organize a second international summit in Asia in early Fall 2018. Working with the U.K. Royal Society and other national academies, the planning committee develop an agenda for the summit that will summarize scientific advances since the 2015 summit and explore such issues as: 1) potential benefits and risks inherent in conducting this research and in considering clinical applications; 2) ethical and cultural perspectives; 3) legal, regulatory, and policy considerations; and 4) public outreach and engagement. The meeting will address these issues from various international perspectives.
The 2.5 day summit will include formal presentations and discussions from a diverse group of international experts. The summit will encourage public dialogue. It is envisioned that the summit will involve 200-300 participants. A brief rapporteur-authored proceedings will be issued following the summit.
Collaborators
Committee
Chair
Member
Member
Member
Member
Member
Member
Member
Member
Member
Member
Member
Member
Anne-Marie C. Mazza
Staff Officer
Sponsors
Burroughs Wellcome Fund
National Institutes of Health
Wellcome Trust